Minami Hironobu | Division Of Oncology/hematology National Cancer Center Hospital East

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
Twelve Novel Single Nucleotide Polymorphisms in the CES2 Gene Encoding Human Carboxylesterase 2 (hCE-2)
Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
日本人におけるヒトSLC29A1の新規遺伝子多型の同定
Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
Genetic Variations and Haplotypes of UGT1A4 in a Japanese Population
Genetic Polymorphisms of UGT1A6 in a Japanese Population
Genetic Variations of the AHR Gene Encoding Aryl Hydrocarbon Receptor in a Japanese Population
Three Novel Single Nucleotide Polymorphisms in UGT1A9
Novel Genetic Polymorphisms in the NR3C1 (Glucocorticoid receptor) Gene in a Japanese Population
Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
Three novel single nucleotide polymorphisms in UGT1A10
Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases
Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors
Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
Population pharmacokinetic and pharmacodynamic analysis for time courses of docetaxel-induced neutropenia in Japanese cancer patients
Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers : A phase I study in Japanese patients
Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
Review of primary unknown cancer : cases referred to the National Cancer Center Hospital East
Phase I dose escalation and pharmacokinetic study of oral enzastaurin (LY317615) in advanced solid tumors

もっと見る

スポンサーリンク